• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPharmaceutical Industry

Pharmaceutical Industry

Page 83 of 100
AstraZeneca Plc Is Tougher Pfizer Inc. Target as Possible Bid Looms
Health
Some Popular Heartburn Drugs Have Been Linked to Dementia
By Claire GrodenFebruary 16, 2016
Donald Trump Campaigns In New Hampshire Ahead Of Primary
Health
Trump Somehow Plans to Negotiate Drug Prices to Zero
By Laura LorenzettiFebruary 12, 2016
BRITAIN-PHARMACEUTICAL-GSK
Health
GlaxoSmithKline Fined $54.3 Million for Preventing Generic Competition
By Laura LorenzettiFebruary 12, 2016
House Oversight Hearing On Prescription Drug Price Increases
Arts & Entertainment
Martin Shkreli Just Offered Kanye West $10 Million For His New Album
By Ben GeierFebruary 11, 2016
Fortune Global Forum 2015
Leadership
Theranos May Lose Its Biggest Blood-Testing Customer
By ReutersFebruary 11, 2016
Mylan Buys Abbott Laboratories Generic Drug Business For $5.3 Billion
Health
Mylan Reaches $7.2 Billion Deal for Meda
By Laura LorenzettiFebruary 10, 2016
Medical Records Archive - IMS Health
Health
This Little-Known Firm Is Getting Rich Off Your Medical Data
By Adam TannerFebruary 9, 2016
Drugs From European Pharmaceuticals Companies As Stocks Outperformed The Stoxx 600 Index By 1.2 percentage Points
Health
U.S. Is Probing a Possible Half-Billion Dollar Health-Care Fraud
By Michal AddadyFebruary 7, 2016
132093105
MPW
Dear Biopharma Bros, Stop Treating Women Like ‘Chattel’
By Valentina ZaryaFebruary 5, 2016
Controversial Former Pharmaceutical CEO Martin Shkreli Testifies On Oversight In Drug Market
Health
Martin Shkreli Calls U.S. Lawmakers ‘Imbeciles’
By Laura LorenzettiFebruary 4, 2016
House Oversight Hearing On Prescription Drug Price Increases
Health
How Martin Shkreli Is ‘Trashing’ the Pharma Industry
By Laura LorenzettiFebruary 4, 2016
Former KaloBios Pharmaceuticals Chief Executive Officer Martin Shkreli Court Appearance
Health
Martin Shkreli Seriously Didn’t Care About Jacking Up Drug Prices
By Laura LorenzettiFebruary 3, 2016
Merck & Co. diabetes treatment Januvia sits is arranged for
Finance
Merck’s Blockbuster Drugs Are Losing Steam
By ReutersFebruary 3, 2016
Views Of A CVS Caremark Corp. Store Ahead Of Earns
Retail
CVS Opens First Pharmacies Within Target Stores
By Phil WahbaFebruary 3, 2016
Martin Shkreli, CEO Reviled for Drug Price Gouging, Arrested on Securities Fraud Charges
Health
Top-Selling Prescription Drugs Have Seen Huge Price Hikes
By Claire GrodenFebruary 2, 2016
1...
  • 81
  • 82
  • 83
  • 84
  • 85
...100
Most Popular
Big Tech
As Big Tech showers employees with perks to win the talent war, Nvidia built a nearly $5 trillion company by making people pay for their own lunchplaceholder alt text
By Marco Quiroz-GutierrezJuly 1, 2026
Success
MacKenzie Scott alone accounted for one-third of America's $19.2 billion in megagifts last yearplaceholder alt text
By Sydney LakeJune 25, 2026
Personal Finance
Current price of oil as of July 1, 2026placeholder alt text
By Joseph HostetlerJuly 1, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.